Schizophrenia News and Research

Latest Schizophrenia News and Research

Report reveals urgent need to improve physical health of people with Schizophrenia

People with schizophrenia often die prematurely. However researchers from the University of Glasgow and NHS Greater Glasgow assert that much of the excess mortality of schizophrenia is preventable through lifestyle changes and the treatment of common diseases.

27 Apr 2005

Psychotherapy may improve schizophrenic symptoms

Two articles published in the May-June issue of Psychotherapy and Psychosomatics survey the recent evidence which is available for the psychotherapy of schizophrenia.

23 Apr 2005

Aging population correlates with a switch from acute infectious diseases to chronic diseases as the major cause of morbidity and mortality

Some diseases like ulcers and certain types of cancer, once thought to be primarily related to lifestyle factors, are now known to be caused by microorganisms, and many more syndromes, including some psychiatric conditions, may have a connection to infection, according to a report released today by the American Academy of Microbiology.

22 Apr 2005

Gene may boost schizophrenia risk

Clues about how a suspect version of a gene may slightly increase risk for schizophrenia are emerging from a brain imaging study by the National Institutes of Health's (NIH) National Institute of Mental Health (NIMH). The gene variant produced a telltale pattern of activity linked to production of a key brain messenger chemical.

21 Apr 2005

Why people get drowsy and fall asleep, and how caffeine blocks that process

When cells in a certain part of the brain become overworked, a compound in the brain kicks in, telling them to shut down. This causes people to become drowsy and fall asleep. Alter that natural process by adding coffee or tea, and the brain compound – called adenosine – is blocked, and people stay awake.

20 Apr 2005

Electroshock therapy speeds improvement in schizophrenia patients

Shock therapy, a controversial practice conjuring frightening images of behavior control, still has a place in schizophrenia treatment, a newly updated research review shows.

20 Apr 2005

Breakdown in brain cell communication may contribute to the most common biochemical cause of mental retardation

The process is akin to a baseball game gone bad. Imagine if a pitcher were joined by six players simultaneously winding up on the mound. Crouched behind home plate, the single catcher would soon be overwhelmed. Even if the coach sent in teammates to catch the extra balls, confusion would reign on the field.

12 Apr 2005

FDA issues public health advisory for antipsychotic drugs

The Food and Drug Administration (FDA) has issued a public health advisory to alert health care providers, patients, and patient caregivers to new safety information concerning an unapproved (i.e., “off-label”) use of certain drugs called “atypical antipsychotic drugs.”

12 Apr 2005

FDA wants warnings put on antipsychotic drugs

The Food and Drug Administration (FDA) has issued a public health advisory to health care providers, patients, and caregivers to alert them to new safety information about the use of certain unapproved or off label drugs which come under the category of “atypical antipsychotic drugs.”

11 Apr 2005

Ephrins may influence learning

A Burnham Institute study has found that one of the cell's largest families of signaling molecules, called ephrins, which are known to regulate the development of nerve cells, also controls nerve cells' ability to engulf critical chemicals and proteins for learning and memory.

11 Apr 2005

Findings could lead to improved treatments for schizophrenics, amphetamine abusers

An Oregon Health & Science University researcher is among an international team closing in on why many people with schizophrenia and other psychotic disorders are "supersensitive" to the powerful neurotransmitter dopamine.

10 Apr 2005

Florida sues drug company for Medicaid fraud

Charlie Crist, Florida's Attorney General is taking three pharmaceutical companies to court for $25 million, accusing them of illegally inflating prices on generic drugs used to treat depression, schizophrenia, seizures and angina.

6 Apr 2005

Metabolic side effects of antipsychotics are known, but rarely monitored

Psychiatrists are doing a “modest” job of monitoring for weight gain, diabetes and other metabolic problems that may result from use of the newer antipsychotics for schizophrenia, researchers say.

5 Apr 2005

New antipsychotic drug prevents brain loss in schizophrenia

A new brain imaging study of recently diagnosed schizophrenia patients has found, for the first time, that the loss of gray matter typically experienced by patients can be prevented by one of the new atypical antipsychotic drugs, olanzapine, but not by haloperidol, an older, conventional drug.

4 Apr 2005

Different antipsychotic medications may have different effects on brain volume in patients with first episode of psychosis

After a first psychotic episode, patients who were treated with an atypical antipsychotic medication had less change in brain volume compared with patients treated with a conventional antipsychotic medication, according to an article in the April issue of Archives of General Psychiatry.

4 Apr 2005

New drug to treat chronic hepatitis B

The U.S. Food and Drug Administration (FDA) has given approval for a new drug to treat the potentially life-threatening disease Chronic hepatitis B.

30 Mar 2005

Images of brain activity may hold clues to the onset of schizophrenia

Images of brain activity may hold clues to the onset of schizophrenia in people at high risk for the disease, according to a study headed by psychiatry researchers at the University of North Carolina at Chapel Hill School of Medicine.

21 Mar 2005

Researchers identify biochemical target that could lead to a new class of antibiotics to fight TB

A worldwide health problem, tuberculosis kills more people than any other bacterial infection. The World Health Organization estimates that two billion people are infected with TB, and that two million people die each year from the disease.

14 Mar 2005

New understanding to how cells in auditory system organize before hearing develops

Generations of neuroscientists have been indoctrinated into believing that our senses, thoughts, feelings and movements are orchestrated by a communication network of brain cells, or neurons, each responsible for relaying one specific chemical message called a neurotransmitter.

7 Mar 2005

Dopamine sheds new light on drug addiction

A paper published in the current issue of Science has challenged beliefs about the role of dopamine in the brain, which could lead to new treatments for Parkinson’s disease, schizophrenia and drug addiction. The research suggests that dopamine has a far wider, less specialised role than previously hypothesised.

3 Mar 2005